Martin T P C, Tzifa K, Kowalski C, Holder R L, Walsh R, Irving R M
Department of Otolaryngology, Walsall Manor Hospital, Walsall, UK.
Clin Otolaryngol. 2008 Jun;33(3):228-35. doi: 10.1111/j.1749-4486.2008.01715.x.
To determine whether patients with small to medium sized acoustic neuromas managed conservatively suffer reduced rates of facial nerve and hearing preservation when compared with patients undergoing primary surgery.
An intention-to-treat comparison between patients managed conservatively at first presentation and those managed with primary surgery.
Tertiary referral neurotological centre in Birmingham, UK.
Data were drawn from our database of 487 sporadic acoustic neuromas managed from 1997 to present day.
Facial nerve status (assessed using the House-Brackmann system) was collated for all conservatively managed patients (n = 167) and compared with that expected when calculated from primarily surgically managed tumours of equivalent size (n = 121). A chi-square test was employed to test the statistical significance of any difference. Hearing preservation (maintenance of AAO-HNS Class) in patients presenting with Class A or B hearing was compared between conservatively managed patients and those with primary surgical management.
Observed facial nerve preservation in conservatively managed patients was significantly better (P < 0.001) than expected when calculated from rates of facial nerve preservation in surgically managed patients. Hearing preservation was also significantly more successful in conservatively managed patients (Pearson chi-square: P < 0.000).
An initial period of conservative management is a safe and reasonable management policy in all acoustic neuromas up to 2 cm in size at the cerebello-pontine angle. Given that there are no failsafe ways of deciding potential for growth in acoustic neuromas, initial conservative management of these tumours offers superior hearing and facial nerve preservation when compared with primary surgical treatment.
确定与接受初次手术的患者相比,接受保守治疗的中小型听神经瘤患者面神经保留率和听力保留率是否降低。
对初次就诊时接受保守治疗的患者与接受初次手术治疗的患者进行意向性治疗比较。
英国伯明翰的三级转诊神经耳科学中心。
数据来自我们1997年至今管理的487例散发性听神经瘤数据库。
对所有接受保守治疗的患者(n = 167)整理面神经状况(使用House-Brackmann系统评估),并与根据同等大小的初次手术治疗肿瘤计算出的预期情况进行比较(n = 121)。采用卡方检验来检验任何差异的统计学显著性。比较了接受保守治疗的患者与接受初次手术治疗的患者中听力为A或B级的患者的听力保留情况(美国耳鼻咽喉头颈外科学会分级的维持情况)。
接受保守治疗的患者中观察到的面神经保留情况明显优于(P < 0.001)根据手术治疗患者的面神经保留率计算出的预期情况。接受保守治疗的患者听力保留也明显更成功(Pearson卡方检验:P < 0.000)。
对于所有位于桥小脑角、大小达2 cm的听神经瘤,初始阶段的保守治疗是一种安全合理的治疗策略。鉴于没有确定听神经瘤生长潜力的万无一失的方法,与初次手术治疗相比,这些肿瘤的初始保守治疗能提供更好的听力和面神经保留效果。